๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Thrombotic Microangiopathies

A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia NCT06776510Phase 1, Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: nicotinamide adenine dinucleotid/nicotinamide mononucleotide Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial NCT06992128Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Romiplostim N01 combined with dexamethasone, Dexamethasone monotherapy Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) NCT07234019Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab๏ผˆAnti-CD38 Monoclonal Antibody๏ผ‰, Rituximab Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites๐Ÿ“ Glendale๐Ÿ“ Los Angeles๐Ÿ“ Lone Tree Incyte Corporation ยท Tests: INCA000585 A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP) NCT06094881Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Obinutuzumab Injection [Gazyva] Avatrombopag in the Treatment of Pediatric Immune Thrombocytopenia NCT06281327Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Avatrombopag Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) NCT06838962Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Daratumumab Injection The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) NCT07065968Phase 23 sites๐Ÿ“ Beijing๐Ÿ“ Beijing๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Teriflunomide, Dexamethasone Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMA NCT05855083Phase 216 sites๐Ÿ“ San Diego๐Ÿ“ Gainesville๐Ÿ“ Boston Omeros Corporation ยท Tests: Biological: narsoplimab Post-transplant Thrombotic Microangiopathy: Evaluation of Outcomes at the Bologna Kidney Transplant Centre NCT06759961n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Construction of a Database for TMA NCT05634928n/a1 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: collection data An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases NCT07174843EARLY Phase 11 site๐Ÿ“ Shanghai Shanghai Cell Therapy Group Co.,Ltd ยท Tests: CD19/CD22/BCMA CAR-T cells(BZE2204) SG301-SC Injection Safety Study in Subjects With Primary ITP Patients NCT07710248Phase 222 sites๐Ÿ“ Fuzhou๐Ÿ“ Guangzhou๐Ÿ“ Liuzhou Hangzhou Sumgen Biotech Co., Ltd. ยท Tests: low dose group, high dose group, Placebo group BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: BCMA-CD19 CAR-T therapy OM336 in Autoimmune Cytopenias NCT07083960Phase 17 sites๐Ÿ“ Duarte๐Ÿ“ Washington D.C.๐Ÿ“ Ann Arbor Lakefront Biotherapeutics West LLC ยท Tests: OM336 Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients NCT07059026n/a1 site๐Ÿ“ Buenos Aires ITAC (Instituto de Trasplantes y Alta Complejidad) Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura NCT04323748Phase 11 site๐Ÿ“ Vahalla New York Medical College ยท Tests: rituxan Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP) NCT07362199Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Rituximab combined with Daratumumab๏ผˆAnti-CD38 Monoclonal Antibody๏ผ‰ Eltrombopag Induced Liver Dysfunction During Treatment of Immunethrombocytopenic Purpura NCT07093606NA1 site๐Ÿ“ Sohag Sohag University ยท Tests: Eltrombopag Inaticabtagene Autoleucel Injection in the Treatment of Refractory Systemic Lupus Erythematosus-related Immune Thrombocytopenia NCT06826430Phase 11 site๐Ÿ“ Beijing Juventas Cell Therapy Ltd. ยท Tests: Inaticabtagene autoleucel Injection A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia NCT05214391Phase 21 site๐Ÿ“ Tianjin Institute of Hematology & Blood Diseases Hospital, China ยท Tests: Zanubrutinib A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP) NCT07421167Phase 219 sites๐Ÿ“ Chandler๐Ÿ“ Fayetteville๐Ÿ“ Torrance Novartis Pharmaceuticals ยท Tests: ianalumab, thrombopoietin receptor agonist (TPO-RA) A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia NCT06544499Phase 394 sites๐Ÿ“ Phoenix๐Ÿ“ Los Angeles๐Ÿ“ Oceanside argenx ยท Tests: Efgartigimod IV, Placebo IV Safety, Tolerability, and Efficacy of NVG-2089 in Participants With Immune Thrombocytopenia NCT07095127Phase 23 sites๐Ÿ“ Washington D.C.๐Ÿ“ Boston๐Ÿ“ Greenville Nuvig Therapeutics, Inc. ยท Tests: NVG-2089 Safety and Efficacy of Eculizumab in High-risk TA-TMA NCT07707687Phase 28 sites๐Ÿ“ Changsha๐Ÿ“ Hangzhou๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: Eculizumab ITP Registry and Accompanying Biospecimen Collection NCT05152238n/a64 sites๐Ÿ“ Aachen๐Ÿ“ Altenburg๐Ÿ“ Aschaffenburg Jena University Hospital A Phase 1/2 Study of ESG206 in Patients With Primary Immune Thrombocytopenia NCT06853444Phase 1, Phase 21 site๐Ÿ“ Jinan Shanghai Escugen Biotechnology Co., Ltd ยท Tests: ESG206, ESG206, ESG206, ESG206 TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment Termination NCT06478537Phase 21 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: Hetrombopag Olamine, Aspirin A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune Thrombocytopenia NCT06900920Phase 353 sites๐Ÿ“ Hefei๐Ÿ“ Wuhu๐Ÿ“ Beijing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. ยท Tests: TQB3473 Tablets, TQB3473 Placebo Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy NCT07347990NA1 site๐Ÿ“ Hangzhou First Affiliated Hospital of Zhejiang University ยท Tests: iptacopan
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy